Immutep accepted abstracts for presentation at the ESMO Congress 2025, which was held in Berlin.
1 report, 1 independent
Updated Jul 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Immutep accepted abstracts for presentation at the ESMO Congress 2025, which was held in Berlin.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Immutep
Biotechnology company
-
European Society for Medical Oncology
Professional organisation
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireImmutep Announces Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025 SYDNEY, AUSTRALIA, July 28, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ